Fludrocortisone in the treatment of hypotensive disorders in the elderly

Heart

Volumn 76, Issue 6, 1996, Pages 507-509

  Hussain, Raja M ^a   McIntosh, Shona J ^a   Lawson, Joanna ^a   Kenny, Rose Anne ^a,b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

adverse effects; elderly patients; fludrocortisone; hypotensive disorders

Indexed keywords

FLUDROCORTISONE;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYNCOPE;

EID: 0030461530     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.76.6.507     Document Type: Article

References (23)

1. Bannister R, Mathias CJ. Management of postural hypotension in autonomic failure. In: Bannister R, ed. Autonomic Nervous System: A textbook of clinical disorders of the autonomic nervous system. London: Oxford University Press, 1993;589-90.
2. Chobanian AV, Volicer L, Tifft C, Gavras H, Liang C, Faxon D. Mineralocorticoid induced hypertension in patients with orthostatic hypotension. N Engl J Med 1979;301:68-73.
3. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years' experience in diabetes. Diabetes care 1985;8:491-8.
4. The Committee of the New York Heart Association. Diseases of the heart and blood vessels in nomenclature and criteria for diagnosis. 7th ed. Boston, 1973;286.
5. Kapoor WN. Diagnostic evaluation of syncope. Am J Med 1991;90:91-106.
6. McIntosh S, Lawson J, Kenny RA. The clinical characteristics of vasodepressor, cardioinhibitory and mixed carotid sinus syndrome in the elderly. Am J Med 1993;95:203-8.
7. Sutton R, Peterson M, Bringle M, Raviele A, Menozzi C, Giani P. Proposed classification for tilt induced vasovagal syncope. Eur J Card Pac Electrophys 1992;2:180-3.
8. McIntosh S, Da Costa D, Kenny RA. Outcome of an integrated approach to the investigation of dizziness, falls and syncope in elderly patients referred to a syncope clinic. Age Ageing 1993;22:53-8.
9. Campbell JW, Ewing IW, Clarke BJ. Therapeutic experience with fludrocortisone in diabetic postural hypotension. Br Med J 1976;i:872-4.
10. McIntosh S, Da Costa D, Kenny RA. Benefit of fludrocortisone in the treatment of symptomatic vasodepressor carotid sinus syndrome. Br Heart J 1993;69:308-10.
11. Watt SJ, Tooke JE, Perkins CM, Lee MR. The treatment of idiopathic hypotension: a combined fludrocotisone and flurbiprofen regime. Q J Med 1981;198:205-12.
12. Hoeldtke RD, Israel BC. Treatment of orthostatic hypotension with octreotide. Clin Endocrinol Metab 1989;68: 1051-9.
13. Lopes de Fria SR, Zanella MT, Andriolo A, Ribeiro AB. Peripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension. J Clin Pharma Ther 1988;44:670-4.
14. Kaufmann H, Brannan T, Krakoff L, Yahr MD, Mandeli J. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine), Neurology 1988;38:951-6.
15. Ward C, Kenny RA. Observations on midodrine in a case of vasodepressor neurogenic syncope. Clin Aut Res 1995; 5:257-60.
16. Biaggioni I, Zygmunt D, Haile V, Robertson D. Pressor effect of inhaled ergotamine in orthostatic hypotension. Am J Cardiol 1990;65:89-92.
17. West JN, Stallard TJ, Dimmitt SB, Smith SA, Williams A, Littler W. Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy: Shy-Drager syndrome. Q J Med 1990;74:209-13.
18. Grubb Blair P, Samoil D, Kosinski D, Wolfe D, Lorton M, Madu E. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am Heart J 1994;97:366-8.
19. Matsubara S, Sawa Y, Yokoji H, Takamori M. Shy Drager syndrome, effect of fludrocortisone and L-threo-3, 4-dihydroxyphenyllserine on the blood pressure and regional cerebral blood flow. J Neurol Neurosurg Psychiat 1990;53:994-7.
20. Sra JS, Murphy VS, Shen YH, Troup PJ, Avital B. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 1993;19:402-8.
21. Milstein S, Buetikofer J, Dunnigan A, Benditt DG, Gornick C, Reyes WJ. Usefulness of disopyramide for prevention of upright tilt-induced hypotension and bradycardia. Am J Cardiol 1990;65:1339-44.
22. Kosinski DJ, Grubb BP, Temesy-Armos PN. The use of serotonin re-uptake inhibitors in the treatment of neurally mediated cardiovascular disorders. J Serotonin Res 1994;1:85-90.
23. Lipsitz L. Abnormalities in blood pressure regulation. In: Kenny RA, ed. Syncope in the Elderly. London: Chapman and Hall, 1996;33-46.